Negligent Misrepresentation Claim Tossed in Mo. Federal Belviq Case



DOCUMENTS
  • Order


KANSAS CITY, Mo. — A Missouri federal judge dismissed a negligent misrepresentation claim in a lawsuit concerning the recalled weight loss drug Belviq, ruling that it failed to meet the heightened pleading requirements of Federal Rule of Civil Procedure 9(b).

In an Oct. 14 order, Judge Greg Kays of the U.S. District Court for the Western District of Missouri explained that because the claim sounds in fraud, the heightened pleading requirement applies.

Amy Davis filed the action against Arena Pharmaceuticals Inc. and Eisai, alleging her use of Belviq caused or significantly contributed to her development of breast cancer.

Belviq, originally …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

February 09, 2022 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin’s Philips CPAP, BiPAP & Ventilator MDL Conference

December 14, 2021 - Pittsburgh, PA
The Omni William Penn Hotel

MORE DETAILS